644
Views
166
CrossRef citations to date
0
Altmetric
Clinical Study

Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma

Pages 496-501 | Published online: 01 May 2008

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.